₹ 1.9
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Vivanza Biosciences Limited is a pharmaceutical firm specializing in the creation and commercialization of medicinal products. Among its offerings, the company prominently features Intravenous (IV) Fusion solutions. This enterprise was founded on March 3, 1982, and maintains its primary operational base in Ahmedabad, India.
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. Specifically, the stock is fairly valued on P/E, overvalued on EV
Data is available to registered users only